when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Venclexta · news · pharmadog

← back to Venclexta

News mentioning Venclexta

18 stories

Jul 30, 26Chutes & Ladders—Legend CEO departs without successor in placefiercebiotech

Jul 27, 26Sarepta names former AbbVie R&D exec Michael Severino as next CEObiospace

May 15, 26Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workersbiopharma dive

May 14, 26BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclextaendpoints

May 13, 26Dr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical Practiceonclive

May 13, 26FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AMLonclive

May 13, 26FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphomaonclive

May 13, 26Dr Dinardo on the FDA Approval of Decitabine/Cedazuridine Plus Venetoclax in AMLonclive

May 13, 26Combination and Sequencing Strategies in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Treatment Sequencing in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Patient Selection for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Alpha-Emitting Therapies in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Combination Radiopharmaceutical Approaches in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Radiopharmaceutical Strategies in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26CLL-321 Trial Efficacy and Safety Results Analysisonclive

May 13, 26BRUIN CLL-321 Trial Impact and Treatment Selectiononclive

May 13, 26Biomarker-Driven Treatment Decisions and Managing Progression After Frontline Immunotherapyonclive

May 8, 26Dr Gruenbaum on Where Alternative Options to BTK Inhibitors Stand in MCLonclive